BACK TO PODCASTS
Intersect
One-Two Punch to Cancer
April 27, 2021
24 min
Thorsten Melcher Ph.D., CBO at RefleXion, and Dr. Giovanni Selvaggi, CEO and CMO at Xcovery, discuss advances in two key areas that could mean a longer life for more Stage 4 patients. The watchwords are customization and personalization. The finding that the customized pairing of two therapies, used in combination, versus in a sequence, creates a synergistic effect, is coupled with the realization every patient’s cancer is personalized to their unique system. Developing a plan that includes a patient assessment, multiple treatment options, and how best to combine them, is a promising new direction.
Speakers
-
Giovanni Selvaggi, M.D.
CEO Xcovery
-
Thorsten Melcher, Ph.D.
Chief Business Officer, RefleXion
735-00033 Rev A
LISTEN ON
Spotify Podcasts
Apple Podcasts
Google Podcasts
RSS